Medicare Enrolled
Dr. David Kang, M.D.
Urology Physician · Monroe, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kang
Dr. David Kang is an urology physician in Monroe, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kang performed 1,454 Medicare services across 1,261 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kang received a total of $11,029 from 60 pharmaceutical and/or device companies across 487 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 46% volume in NC
$11,029 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,454
Medicare services
Top 46% in NC for urology physician
1,261
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $89 | $158 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
213 | $4 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
212 | $63 | $110 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
174 | $7 | $45 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
140 | $177 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $118 | $263 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
70 | $79 | $185 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
37 | $105 | $295 |
| Injection, garamycin, gentamicin, up to 80 mg | 31 | $2 | $7 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
29 | $168 | $677 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
29 | $7 | $220 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
28 | $237 | $826 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
26 | $3 | $17 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $93 | $1,484 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $171 | $611 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $306 | $1,850 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
17 | $19 | $264 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
19.3% medium
75.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,029
Total received (2018-2024)
Avg $1,576/year across 7 years
Top 16% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
487
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,751 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,045
2023
$2,093
2022
$2,485
2021
$1,326
2020
$903
2019
$1,068
2018
$1,110
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UROGEN PHARMA, INC.
$297
Sumitomo Pharma America, Inc.
$212
Endo USA, Inc.
$185
Astellas Pharma US Inc
$181
Dendreon Pharmaceuticals LLC
$160
Laborie Medical Technologies Corp.
$156
Olympus America Inc.
$129
Myriad Genetic Laboratories, Inc.
$121
Boston Scientific Corporation
$92
PFIZER INC.
$87
Endo Pharmaceuticals Inc.
$61
ABBVIE INC.
$59
Medtronic, Inc.
$56
Ferring Pharmaceuticals Inc.
$48
COLOPLAST CORP
$46
Blue Earth Diagnostics Limited
$32
PROGENICS PHARMACEUTICALS, INC.
$22
Janssen Biotech, Inc.
$22
Teleflex LLC
$22
Merck Sharp & Dohme LLC
$21
ConvaTec Inc.
$19
180 Medical, Inc.
$19
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,488
Medtronic, Inc.
$1,289
Boston Scientific Corporation
$790
PFIZER INC.
$736
Sumitomo Pharma America, Inc.
$629
Endo Pharmaceuticals Inc.
$604
UroGen Pharma, Inc.
$551
UROGEN PHARMA, INC.
$524
Dendreon Pharmaceuticals LLC
$417
Laborie Medical Technologies Corp.
$317
Coloplast Corp
$287
Antares Pharma, Inc.
$264
Myovant Sciences Inc.
$245
Janssen Biotech, Inc.
$193
Endo USA, Inc.
$185
Medtronic USA, Inc.
$175
ABBVIE INC.
$142
Avadel Specialty Pharmaceuticals, LLC
$129
Olympus America Inc.
$129
NeoTract Inc.
$125
BOSTON SCIENTIFIC CORPORATION
$125
Myriad Genetic Laboratories, Inc.
$121
Axonics, Inc.
$111
ConvaTec Inc.
$110
TOLMAR Pharmaceuticals, Inc.
$105
AMAG Pharmaceuticals, Inc.
$97
NxThera, Inc.
$88
COLOPLAST CORP
$79
Teleflex LLC
$56
Merck Sharp & Dohme LLC
$56
UROVANT SCIENCES INC
$56
Blue Earth Diagnostics Limited
$52
AngioDynamics, Inc.
$52
AbbVie, Inc.
$50
Ferring Pharmaceuticals Inc.
$48
AbbVie Inc.
$45
Progenics Pharmaceuticals, Inc.
$45
Bayer HealthCare Pharmaceuticals Inc.
$43
ACCORD HEALTHCARE, INC.
$40
HealthTronics Mobile Solutions, LLC
$33
Tolmar, Inc.
$30
Allergan, Inc.
$29
Rochester Medical Corporation
$29
Zyla Life Sciences
$28
Zyla Life Sciences, Inc.
$26
Acerus Pharmaceuticals Corporation
$25
PROGENICS PHARMACEUTICALS, INC.
$22
Clarus Therapeutics Inc.
$21
Merck Sharp & Dohme Corporation
$20
ABC Home Medical Supply, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Hollister Incorporated
$19
180 Medical, Inc.
$19
Smith+Nephew, Inc.
$17
Cook Medical LLC
$16
Travere Therapeutics, Inc.
$16
Retrophin, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Mission Pharmacal Company
$11
Intuitive Surgical, Inc.
$6
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AMS · AMS 700 · AVEED · AdVance XP · Altis · Androgel · Axonics · BOTOX · CAMCEVI · COOK MEDICAL LASERS · CURE CATHETER · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL - THERAPIES · GENTLECATH · INTERSTIM · INTRAROSA · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LITHOCLAST · LITHOVUE · LUPRON DEPOT · LithoVue · Luja Coude · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Mobile Laser Services · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PELVIC FLOOR REPAIR · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PVC · PYLARIFY · Porges Coloplast · RESTORELLE · REZUM · Rezum · Rezum Generator · SPEEDICATH · SPRIX · STRAVIX · SWISS LITHOCLAST TRILOGY · Seglentis · SpeediCath · TOVIAZ · TRIA · Titan · Tria Firm · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZORVOLEX · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
20
Per 100K population
8.2
County median income
$99,243
Nearest hospital
ATRIUM HEALTH UNION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kang is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of NC peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kang performed 268 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kang receive payments from pharmaceutical companies?
Yes. Dr. Kang received a total of $11,029 from 60 companies across 487 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kang's costs compare to other urology physicians in Monroe?
Dr. Kang's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Monroe
Browse urology physicians in Monroe ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology